Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gonzales-Luna, Anne J.
344  Ergebnisse:
Personensuche X
?
1

Reduced Vancomycin Susceptibility in Clostridioides diffici..:

Eubank, Taryn A ; Dureja, Chetna ; Garey, Kevin W..
Clinical Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Antibacterial activity of ibezapolstat against antimicrobia..:

Bassères, Eugénie ; Eubank, Taryn A. ; Begum, Khurshida...
Antimicrobial Agents and Chemotherapy.  68 (2024)  3 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
3

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among P..:

Reveles, Kelly R ; Gonzales-Luna, Anne J ; Golan, Yoav...
Open Forum Infectious Diseases.  11 (2024)  7 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

Gut microbiota changes associated withClostridioides diffic..:

Gonzales-Luna, Anne J. ; Carlson, Travis J. ; Garey, Kevin W.
Gut Microbes.  15 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
5

2164. Resistome patterns associated with vancomycin non-sus..:

Eubank, Taryn A ; Gonzales-Luna, Anne J ; Hanson, Blake M...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

Surveillance of Clostridioides difficile Antimicrobial Resi..:

Gonzales-Luna, Anne J ; Dureja, Chetna ; Eubank, Taryn A..
Clinical Infectious Diseases.  76 (2023)  11 - p. 2038-2039 , 2023
Link: https://doi.org/10.1093/..
 
?
7

702. Efficacy of Fecal Microbiota, Live-jslm After Receipt ..:

Reveles, Kelly R ; Gonzales-Luna, Anne J ; Golan, Yoav...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
8

653. Rapid Change in Microbiome Profiles Regardless of Diag..:

Gonzales-Luna, Anne J ; Litcofsky, Kevin ; Straub, Tim...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
9

682. Novel rpoB mutations and trends in clinical Clostridio..:

Gonzales-Luna, Anne J ; Le, Thanh ; Eubank, Taryn A...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

Fecal Pharmacokinetics and Gut Microbiome Effects of Oral O..:

Jo, Jinhee ; Hu, Chenlin ; Begum, Khurshida...
The Journal of Infectious Diseases.  229 (2023)  1 - p. 273-281 , 2023
Link: https://doi.org/10.1093/..
 
?
11

674. Host and Pathogen Risk Factors for Fulminant Clostridi..:

Chua, Hubert C ; Eubank, Taryn A ; Jo, Jinhee..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
12

Emerging Options for the Prevention and Management of Clost..:

Gonzales-Luna, Anne J. ; Carlson, Travis J. ; Garey, Kevin W.
Drugs.  83 (2023)  2 - p. 105-116 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Preservation of the Innate Immune Response toClostridioides..:

Banegas, Marcela ; Villafuerte-Gálvez, Javier ; Paredes, Rodrigo...
Open Forum Infectious Diseases.  10 (2023)  3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

The Significance of Bayesian Pharmacokinetics in Dosing for..:

Alnezary, Faris S. ; Almutairi, Masaad Saeed ; Gonzales-Luna, Anne J..
Antibiotics.  12 (2023)  9 - p. 1441 , 2023
Link: https://doi.org/10.3390/..
 
?
15

277. A Functional OMICs Evaluation of Omadacycline to Under..:

Jo, Jinhee ; Agyapong, Samantha ; Hu, Chenlin...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
1-15